Your browser doesn't support javascript.
loading
Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma.
Kaufman, G P; Gertz, M A; Dispenzieri, A; Lacy, M Q; Buadi, F K; Dingli, D; Hayman, S R; Kapoor, P; Lust, J A; Russell, S; Go, R S; Hwa, Y L; Kyle, R A; Rajkumar, S V; Kumar, S K.
Afiliación
  • Kaufman GP; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Gertz MA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Dispenzieri A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Lacy MQ; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Buadi FK; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Dingli D; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Hayman SR; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Kapoor P; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Lust JA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Russell S; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Go RS; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Hwa YL; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Kyle RA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Rajkumar SV; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Kumar SK; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Leukemia ; 30(3): 633-9, 2016 Mar.
Article en En | MEDLINE | ID: mdl-26487275
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido